Use of statins and risk of uterine leiomyoma: A cohort study in the UK Biobank

Xue-Feng Jiao; Hailong Li; Linan Zeng; Lu Han; Huazhen Yang; Yao Hu; Yuanyuan Qu; Wenwen Chen; Yajing Sun; Wei Zhang; Donghao Lu; Lingli Zhang

doi:10.1111/jebm.12559

Use of statins and risk of uterine leiomyoma: A cohort study in the UK Biobank

J Evid Based Med. 2023 Dec;16(4):424-427. doi: 10.1111/jebm.12559. Epub 2023 Oct 17.

Authors

Xue-Feng Jiao^{1

2

3

4}, Hailong Li^{1

2

3

4}, Linan Zeng^{1

2

3

4}, Lu Han^{1

2

3

4}, Huazhen Yang^{5

6}, Yao Hu^{5

6}, Yuanyuan Qu^{5

6}, Wenwen Chen^{5

6}, Yajing Sun^{5

6}, Wei Zhang^{5

6}, Donghao Lu^{5

7

8}, Lingli Zhang^{1

2

3

4

9}

Affiliations

¹ Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
² Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
³ NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, NMPA, Chengdu, China.
⁴ Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
⁵ West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
⁶ Medical Big Data Center, Sichuan University, Chengdu, China.
⁷ Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁸ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
⁹ Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.

PMID: 37847602
DOI: 10.1111/jebm.12559

No abstract available

Publication types

Letter

MeSH terms

Biological Specimen Banks
Cohort Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Leiomyoma* / drug therapy
Risk Factors
UK Biobank

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding

2022NSFSC0644/Natural Science Foundation of Sichuan Province